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Technical Report
Abstract
Purpose: The purpose of this study was to conduct quality assurance of a three dimensional conformal radiotherapy (3DCRT) of
two targets in pelvis region planned with single isocenter technique. Methods: A treatment plan was generated with two iden-
tical water phantoms with ionization chamber (IC) sleeves (IC-1 & IC-2), simulated as if targets are in pelvis region, simultane-
ously irradiated with single isocenter technique with a dose prescription of 300 cGy for point dose verification. A two dimen-
sional ion chamber array detector was used for fluence verification. Results: Calculated minimum, mean and maximum dose (in
cGy) for IC-1 & IC-2 were 295, 303 and 307 as per dose volume histogram. The global dose maximum was found to be 307.4
cGy. Measured point doses to both lesions were within ±2.5% of the computed dose. A pass percentage of 97% was obtained
with the set of criteria 3 mm distance to agreement and 3% dose difference for fluence verification. Conclusion: Treatment ex-
ecution of two targets simultaneously with single isocenter can reduce positional errors and delivery time.
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Introduction
Solid tumours in pelvic region present with bilateral hip
bone metastases where critical organs (e.g. bladder and rec-
tum) need to be spared while necessitating their simultane-
ous radio therapeutic treatment. Such treatments are usually
executed using modern radiotherapy techniques such as in-
tensity modulated radiotherapy (IMRT), stereotactic body
radiation therapy (SBRT), rapid arc, volumetric arc radio-
therapy (VMAT), cyberknife® and tomotherapy. In conven-
tion, multiple targets can be treated individually with a set of
beams having their own isocenter. Treatment planning and
execution of multiple targets results in prolongation of
treatment time [starting from pre-treatment quality assurance
(QA), patient positioning, and setup corrections for every
target treatment and treatment delivery]. Another method is
to have a common isocenter, around which the gantry rotates
and delivers the radiation to multiple target sites, one at a
time. This method can considerably reduce the time of
pre-treatment plan QA and execution. Many investigators
have verified the dosimetric quality of a common isocentric
plan to treat multiple tumours especially in brain metastatic
lesions.
Potter et al.1 have investigated the treatment of multiple
brain tumours with 4 bank micro multi leaf collimator
(mMLC) and have found that the single isocentric treatment
plan was as good as multiple isocentric plan, which can re-
duce considerable amount of time in QA & treatment deliv-
ery. Luxton et al.2 treated non-spherical targets in brain with
single isocenter and achieved good dose conformity. Clark et
al.3 have verified the feasibility of single isocenter in VMAT
radiosurgery, for the treatment of multiple brain metastasis
and concluded that it is a better method. Huang et al.4 have
compared the quality of target coverage and dose conformity
with single isocentric VMAT-SRS plans to dynamic confor-
mal arc therapy (DCAT) and they concluded that the DCAT
technique may result in larger low dose regions.
Many authors have studied the validity of single isocentric
plans and concluded that it could be a better option in saving
pre-treatment QA time as well as treatment delivery time
with less systematic errors.5-7 Marks et al. have confirmed
through their investigation that three dimensional conformal
radiotherapy (3DCRT) technique can be a possible alternative
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to radiosurgery with fixed shaped coplanar or non-coplanar
techniques with wedged radiation fields having beams con-
formed to irregular shaped intracranial lesions, as the goal of
both the techniques is to achieve better dose conformity.8
Similar logic can be used to treat multiple lesions simultane-
ously with different/single beam sets conformed to different
lesion sites elsewhere extra cranially which can save
pre-treatment QA time & treatment time appreciably. Plan-
ning of these techniques with 3DCRT using treatment plan-
ning system (TPS), requires a logical approach (different
beam sets conformed to multiple lesions sharing a common
isocenter, having different weight points, the feasibil-
ity/flexibility to use different wedge angles using motorized
wedge option, to obtain better conformal dose coverage.9-11
The objective of this study is to validate a single isocentric
plan using 3DCRT treatment planning technique in terms of
dose conformity and coverage for the treatment of two pel-
vic metastatic lesions (simulated in water phantom) using
composite point dose method and two dimensional (2D) ion
chamber array detector.
Methods and Materials
A case of carcinoma of lung with bilateral hip bone metasta-
ses (targets) in pelvic region was planned for radiotherapy
using common isocenter using 3DCRT technique with CMS
XiO TPS with superposition algorithm (Figure 1). Treatment
was executed with medical linear accelerator (Elekta Com-
pact; Stockholm, Sweden), using 6 MV photon beam at a
dose rate of 350 MU/min with 40 pair multi leaf collimator
(MLC) leaves (projected leaf width 1.0 cm at isocenter) ar-
ranged in two banks and also having motorized wedge facil-
ity.




For the point dose verification (composite dosimetry) of this
plan, same patient geometry was simulated by two identical
water phantoms (having dimensions of 30 cm × 15 cm × 15
cm each) with 0.65 cc ionization chamber (Scanditronix
Farmer Type Chamber FC65) (IC) sleeves were placed side
by side, having surface fiducials. The active volumes of the
two ionization chambers were used to simulate the targets. A
planning computed tomography (CT) scan was acquired along
with ICs placed inside the sleeves (Figure 2) and the images
were exported to the contouring station (CMS Focal Sim).
FIG. 2: CT Simulation of identical water phantoms with ionization
chambers (IC-1 & IC-2) kept inside the sleeves.
FIG. 3: Treatment planning of IC-1 & IC-2 with single isocenter.
FIG. 4: Point dose verification with water phantom and ICs.
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The chamber positions were contoured as IC-1 & IC-2 simu-
lating the bilateral targets in the pelvis in an actual patient. A
combined target (IC-3) was generated with a 5 mm margin
encompassing both IC-1 & IC-2. Contoured CT data set was
exported to CMS XiO TPS for beam placement and dose cal-
culations. A group of six main beams were placed with cen-
tre of IC-3 as isocenter such that three beams with gantry
angles 1800, 2700 and 00 conformed to IC-1 & three beams
with gantry angles 00, 900 and 1800 conformed to IC-2. The
field in field (sub beam) technique was used with different
MLC leaf positions to eliminate the hot spots. In order to
obtain uniform dose distribution around the targets, appro-
priate beam weights, weight points (placed inside the targets)
and different wedge angles were chosen. Superposition algo-
rithm was used for dose calculations. A dose of 300 cGy is
prescribed to the 100% isodose line that is covering both the
targets. The calculated monitoring units (MU) for each field
was normalized to the specified weight points and were ad-
justed such that each target was covered with 95% of isodose
line. The generated plan (Figure 3) was exported and exe-
cuted (Figure 4) using Mosaiq® record and verification system
for point dose verification.
The measurement was carried out with water phantoms and
ICs placed inside the sleeves which were connected to the
electrometers (Scanditronix DOSE1). The measured charge
collected from each electrometer was converted to absorbed
dose after applying correction factors of temperature &
pressure (KTP), polarization(Kpol), saturation (KSat), beam
quality (KQQo) and calibration factor(NDW) of the chamber.
Two dimensional (2D) verification
A 2D ion chamber array detector (I’matriXX) was used for
planar dose verification. This device consists of a 1020 vented
ion chamber array detectors arranged in 32 × 32 grids. The
each chamber volume is 0.08 cm3 with the height of 5 mm
and diameter of 4.5 mm. The maximum dose rate detectable
by the detectors is 5 Gy/min and minimum of 0.1 Gy/min.
The bias voltage required for the matrix system is 500 ± 30V.
The maximum field of view is 24 × 24 cm2. The matrix device
can be directly connected to computer via standard Ethernet
interface to acquire the measurements. The I′matriXX device
with 5 cm solid water phantom (SP-34) positioned above it
was scanned with 2 mm CT slice thickness. In order to verify
the TPS generated plan, a verification plan was produced
with CT data of the detector system to estimate the fluence.
In the verification plan, all gantry and collimator angels were
set to 0 degrees and exported to the scanned detector system
with the detector plane positioned at isocenter. Generated
verification plan was exported and executed (Figure 5) using
Mosaiq® record and verification system for planar dose veri-
fication with I′matriXX device.
FIG. 5: 2D dose verification with I’MatriXX.
The beam central axis was made perpendicular to the
I’matriXX measurement level at the center of the measure-
ment area during the measurement. By executing the verifi-
cation plan, the cumulative fluence at the detector plane was
calculated and transferred to the Omnipro software for
comparison. Dose distributions obtained with I’matriXX was
rescaled at 0.1 cm resolution using OmniPro IMRT analyzing
software. All measured fluence was compared with TPS dose
plane by 2D gamma evaluation using 3% dose difference and
3 mm distance-to-agreement (DTA) criteria.
Results
The mean meter readings (M) obtained by point dosimetry
method with two 0.6 cc FC65 ionization chambers (IC-1 &
IC-2) are shown in Table 1.
The final dose measurements were obtained using NDWbased
formalism12 and compared with the TPS calculated values as
shown in Table 2.
A deviation of -1.87% and -1.30% for IC-1 and IC-2 target
was observed from the calculated value. The minimum,
maximum and mean dose (cGy) covered by the IC-1 & IC-2
volumes were 295, 307 and 303 as per dose volume histo-
gram index from the generated treatment plan. The global
dose maximum obtained from the plan was 307.4 cGy.
Measured point doses to both lesions were within ± 2% of
the TPS calculated dose. A pass percentage of 97% was ob-
tained with the set criteria of 3 mm distance to agreement
(DTA) and 3% dose difference for fluence verification (Fig-
ure 6).
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Cumulative charge (*nC) collected
IC-1 IC-2
Trial-1 Trial-2 Trial-1 Trial-2
2700 RT LAT DIR WEDGE 153 6.93 6.92 18.36 18.20
00 RT ANT DIR WEDGE 196 7.02 7.01 36.76 36.55
00 RT ANT DIR SUB 25 7.04 7.02 40.67 40.38
00 LT ANT DIR WEDGE 232 10.18 10.16 40.69 40.36
00 LT ANT DIR SUB1 20 14.74 14.71 40.70 40.34
00 LT ANT DIR SUB2 29 30.48 30.43 40.80 40.31
900 LT LAT DIR WEDGE 203 46.47 46.27 46.98 46.27
1800 LT POST DIR SUB 41 46.56 46.36 57.34 46.27
1800 LT POST DIR WEDGE 415 46.59 46.39 61.10 60.24
1800 RT POST DIR SUB 20 59.91 59.67 61.24 60.24
1800 RT POST DIR 109 61.87 61.62 61.25 60.24
Mean Meter Reading (M) 61.75 60.75
*nC = nano Coulombs
TABLE 2: Percentage deviation between measured and TPS calculated point dose.
Measured Mean dose (cGy) = M x TCF@ TPS calculated Mean dose (cGy) Percentage Deviation (%)
IC-1 IC-2 IC-1 IC-2 IC-1 IC-2
297.4 299.1 302.8 303.0 -1.78 -1.29
@TCF = Total Correction Factor (NDWx KTPx Kpolx KSatx KQQo)12
FIG. 6: Evaluation of 2D fluence verification using I’mRTMatriXX™ device.
Discussion
In the present study, treatment planning of two targets in
pelvic region simultaneously treated with common isocenter
using 3D-CRT technique was studied and the delivery accu-
racy was checked in terms of point dose and fluence meas-
urements. Earlier a similar kind of attempt has been made by
several investigators for the treatment of multiple intracra-
nial lesions using highly sophisticated state of art of radio-
therapy with algorithms based on inverse planning.1-7 An-
other group of investigators have tried to achieve the same
target using 3DCRT techniques to treat multiple intracranial
lesions with coplanar & non-coplanar beams.8 Keeping the
ultimate goal of radiotherapeutic treatment in view, i.e., to
achieve maximum target/CTV dose coverage (95% -107%
isodose coverage to CTV/PTV) & conformity with maximum
possibility of normal tissue sparing, the idea of treating
two/multiple targets (intra or extracranial) simultaneously
having a common isocenter is always appreciable in terms of
time consumed in pre-treatment QA and treatment delivery
as well to minimize the setup errors. In contrast the treat-
ment plans with multiple isocenter are time consuming,
error prone, and may attribute many uncertainties in the
setup and positioning resulting in large systematic errors in
the treatment delivery.
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Our study was based on the dose computed in the XiO TPS,
which employs superposition algorithm. Researchers13-16
have shown that computed dosimetric results from one dose
calculation algorithm can vary from that of other dose cal-
culations algorithms such as Acuros XB13, 14, analytical aniso-
tropic algorithm14, 15, and collapsed cone convolution super-
position algorithm16. The validation of a single isocentric
plan for two targets needs to be further investigated in other
TPSs with different dose calculation algorithms.
Conclusion
As the composite point dosimetry results were in agreement
with the TPS calculated dose, the method adopted for treating
two targets with common isocenter simultaneously with
3D-CRT technique is a better option to reduce the
pre-treatment QA and treatment time significantly, at the
same time achieving the required coverage as in other so-
phisticated techniques and higher state of art equipments in
the field of Radiotherapy. This technique can be further
applied to treat multiple targets simultaneously with differ-
ent fraction sizes & doses. This can significantly help in ra-
diobiological control of gross and distant lesions (if any).
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